Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,632.00
-3.00 (-0.18%)
Mar 4, 2025, 10:53 AM CET
Genmab Revenue
In the year 2024, Genmab had annual revenue of 21.53B DKK with 30.67% growth. Genmab had revenue of 6.44B in the quarter ending December 31, 2024, with 35.34% growth.
Revenue
21.53B
Revenue Growth
+30.67%
P/S Ratio
4.88
Revenue / Employee
8.03M
Employees
2,682
Market Cap
103.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.53B | 5.05B | 30.67% |
| Dec 31, 2023 | 16.47B | 1.97B | 13.57% |
| Dec 31, 2022 | 14.51B | 6.09B | 72.33% |
| Dec 31, 2021 | 8.42B | -1.69B | -16.75% |
| Dec 31, 2020 | 10.11B | 4.75B | 88.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.45B |
| Demant | 22.42B |
| Zealand Pharma | 62.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.65B |
| ALK-Abelló | 5.54B |
| GN Store Nord | 17.99B |
Genmab News
- 6 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 11 days ago - EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 12 days ago - Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 14 days ago - Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon - Seeking Alpha
- 17 days ago - Genmab A/S (GMAB) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 17 days ago - Genmab A/S 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 19 days ago - Notice to Convene the Annual General Meeting of Genmab A/S - GlobeNewsWire
- 19 days ago - Genmab AS (GMAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - GuruFocus